Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Baricitinib is effective as a treatment for severe hair loss.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Baricitinib is effective and safe for treating severe alopecia areata.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

The drug combination was safe and showed promise in treating advanced tumors.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

MK-5108 is safe and shows potential against tumors, especially alone.